Editorial: Closing in on the Role of Thymic Stromal Lymphopoietin Inhibition as a Therapeutic Entry Point for Systemic Sclerosis
Publication date
2016-11-01
Authors
Affandi, Alsya J.
Van Roon, J. A G
Editors
Advisors
Supervisors
Document Type
Editorial
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, Immunology and Allergy, Rheumatology, Immunology
Citation
Affandi, A J & van Roon, J A G 2016, 'Editorial : Closing in on the Role of Thymic Stromal Lymphopoietin Inhibition as a Therapeutic Entry Point for Systemic Sclerosis', Arthritis and Rheumatology, vol. 68, no. 11, pp. 2571-2574. https://doi.org/10.1002/art.39815